Nitazoxanide and COVID-19: A review
Article
[키워드] Activation
acute lung injury
acute respiratory distress
acute respiratory distress syndrome
addition
Anti-inflammatory
anti-parasitic drug
anti-SARS-CoV-2
Antiviral
antiviral activity
antiviral property
ARDS
autophagic
cause
cell death
clinical trial
Coronavirus disease 2019
COVID-19
Cytokine storm
Cytokines
distress
drug
effective
finding
IFN
immunological
in silico
in vitro study
Infection
inflammatory disorders
inflammatory reaction
inhibit
Innate immunity
interferon
lung
mammalian
mitigate
Multi-organ damage
nitazoxanide
oxidative stress
pathogenesis of SARS-CoV-2
pro-inflammatory cytokines
pro-inflammatory cytokines.
Prospective Study
Protozoa
Rapamycin
reduce
Respiratory Coronavirus
SARS-CoV-2
SARS-CoV-2 infections
severe cases
syndrome
therapy
Treatment
triggered
viral infections
Viral pneumonia
[DOI] 10.1007/s11033-022-07822-2 PMC 바로가기
[DOI] 10.1007/s11033-022-07822-2 PMC 바로가기